Abstract is: Sangeeta N. Bhatia (born 1968) is an American biological engineer and the John J. and Dorothy Wilson Professor at MIT’s Institute for Medical Engineering and Science and Electrical Engineering and Computer Science (EECS) at the Massachusetts Institute of Technology (MIT) in Cambridge, Massachusetts, United States. Bhatia's research investigates applications of micro- and nano-technology for tissue repair and regeneration. She applies ideas from computer technology and engineering to the design of miniaturized biomedical tools for the study and treatment of diseases, in particular liver disease, hepatitis, malaria and cancer. In 2003, she was named by the MIT Technology Review as one of the top 100 innovators in the world under the age of 35. She was also named a "Scientist to Watch" by The Scientist in 2006.She has received multiple awards and has been elected to the National Academy of Sciences, the National Academy of Engineering, the National Academy of Medicine, and the National Academy of Inventors. Bhatia's dissertation became the basis for Microfabrication in tissue engineering and bioartificial organs (1999).Bhatia co-authored the first undergraduate textbook on tissue engineering, Tissue engineering (2004), written for senior-level and first-year graduate courses with Bernhard Palsson.She was a co-editor of Microdevices in Biology and Medicine (2009) and Biosensing: International Research and Development (2005).
| human | Q5 |
| P268 | Bibliothèque nationale de France ID | 15509738h |
| P5361 | BNB person ID | BhatiaSangeeta1968- |
| P9984 | CANTIC ID | 981058520175906706 |
| P1273 | CANTIC ID (former scheme) | a11062253 |
| P2456 | DBLP author ID | 34/11013 |
| P973 | described at URL | https://sciencehistory.org/stories/magazine/interview-sangeeta-bhatia/ |
| P646 | Freebase ID | /m/07s9llk |
| P227 | GND ID | 1146229941 |
| P1960 | Google Scholar author ID | L-SoYz8AAAAJ |
| P269 | IdRef ID | 075954796 |
| P213 | ISNI | 0000000117004268 |
| P244 | Library of Congress authority ID | n99801815 |
| P5587 | Libris-URI | b8nrwnkv53b1c8w |
| P8189 | National Library of Israel J9U ID | 987007453540205171 |
| P1006 | Nationale Thesaurus voor Auteursnamen ID | 186772726 |
| P691 | NL CR AUT ID | utb2011630668 |
| P1207 | NUKAT ID | n2004082825 |
| P496 | ORCID iD | 0000-0002-1293-2097 |
| P906 | SELIBR ID | 319256 |
| P2611 | TED speaker ID | sangeeta_bhatia |
| P11686 | University of Barcelona authority ID | 981058520175906706 |
| P1580 | University of Barcelona authority ID (former scheme) | a1246472 |
| P214 | VIAF ID | 116681965 |
| P10832 | WorldCat Entities ID | E39PBJgHf7kYPrvtt8ypQ4JRrq |
| P1416 | affiliation | Massachusetts Institute of Technology | Q49108 |
| P6424 | affiliation string | Massachusetts Institute of Technology (MIT) | |
| P166 | award received | Lemelson–MIT Prize | Q551250 |
| Heinz Award | Q5700571 | ||
| Othmer Gold Medal | Q17291441 | ||
| Fellow of the Biomedical Engineering Society | Q59767038 | ||
| Packard Fellowship for Science and Engineering | Q113469875 | ||
| P27 | country of citizenship | United States of America | Q30 |
| P69 | educated at | Massachusetts Institute of Technology | Q49108 |
| Brown University | Q49114 | ||
| Harvard Medical School | Q49121 | ||
| P108 | employer | Massachusetts Institute of Technology | Q49108 |
| University of California, San Diego | Q622664 | ||
| Howard Hughes Medical Institute | Q1512226 | ||
| Koch Institute for Integrative Cancer Research at MIT | Q5234534 | ||
| P734 | family name | Bhatia | Q37443079 |
| Bhatia | Q37443079 | ||
| Bhatia | Q37443079 | ||
| P735 | given name | Sangeeta | Q84591097 |
| Sangeeta | Q84591097 | ||
| P463 | member of | National Academy of Sciences | Q270794 |
| American Academy of Arts and Sciences | Q463303 | ||
| P106 | occupation | engineer | Q81096 |
| P1344 | participant in | World Economic Forum Annual Meeting 2016 | Q114717232 |
| P21 | sex or gender | female | Q6581072 |
| Q35831722 | A Macro-to-Micro Interface for the Control of Cellular Organization |
| Q30539106 | A biophysical indicator of vaso-occlusive risk in sickle cell disease |
| Q28276647 | A combinatorial extracellular matrix platform identifies cell-extracellular matrix interactions that correlate with metastasis |
| Q33855309 | A computational framework for identifying design guidelines to increase the penetration of targeted nanoparticles into tumors |
| Q37060955 | A peptide for targeted, systemic delivery of imaging and therapeutic compounds into acute brain injuries. |
| Q35201294 | Aberrant glycosylation promotes lung cancer metastasis through adhesion to galectins in the metastatic niche |
| Q91518599 | Acidification of Tumor at Stromal Boundaries Drives Transcriptome Alterations Associated with Aggressive Phenotypes |
| Q101236993 | Activatable zymography probes enable in situ localization of protease dysregulation in cancer |
| Q34405319 | An extracellular matrix microarray for probing cellular differentiation |
| Q44270507 | Anisotropic stretch-induced hypertrophy in neonatal ventricular myocytes micropatterned on deformable elastomers |
| Q45055552 | Assessing porcine liver-derived biomatrix for hepatic tissue engineering |
| Q40231003 | Assessment of hepatocellular function within PEG hydrogels |
| Q34684415 | Biodegradable luminescent porous silicon nanoparticles for in vivo applications |
| Q38051414 | Bioengineering methods for analysis of cells in vitro |
| Q30478897 | Biomimetic amplification of nanoparticle homing to tumors |
| Q46013588 | Biomolecular screening with encoded porous-silicon photonic crystals. |
| Q42597124 | Bioresponsive mesoporous silica nanoparticles for triggered drug release |
| Q89581696 | Cancer Cell-Derived Matrisome Proteins Promote Metastasis in Pancreatic Ductal Adenocarcinoma |
| Q24296821 | Cancer vulnerabilities unveiled by genomic loss |
| Q38230357 | Cell and tissue engineering for liver disease |
| Q64976595 | Classification of prostate cancer using a protease activity nanosensor library. |
| Q33319622 | Combinatorial signaling microenvironments for studying stem cell fate |
| Q42356786 | Comparison of Modular PEG Incorporation Strategies for Stabilization of Peptide-siRNA Nanocomplexes. |
| Q37267361 | Computationally guided photothermal tumor therapy using long-circulating gold nanorod antennas |
| Q33524689 | Cooperative nanomaterial system to sensitize, target, and treat tumors |
| Q34674805 | Cooperative nanoparticles for tumor detection and photothermally triggered drug delivery |
| Q28276295 | Critical role for lysyl oxidase in mesenchymal stem cell-driven breast cancer malignancy |
| Q30521273 | DNA-templated assembly of droplet-derived PEG microtissues |
| Q34281226 | Deep, noninvasive imaging and surgical guidance of submillimeter tumors using targeted M13-stabilized single-walled carbon nanotubes |
| Q36960927 | Degradable hydrogels derived from PEG-diacrylamide for hepatic tissue engineering |
| Q47287653 | Depolarization signatures map gold nanorods within biological tissue. |
| Q34538256 | Development of Light-Activated CRISPR Using Guide RNAs with Photocleavable Protectors |
| Q37471523 | Differential proteomics analysis of the surface heterogeneity of dextran iron oxide nanoparticles and the implications for their in vivo clearance |
| Q34282732 | Disease detection by ultrasensitive quantification of microdosed synthetic urinary biomarkers. |
| Q55131866 | Drug-induced amplification of nanoparticle targeting to tumors. |
| Q42389499 | Effect of nanoparticle conjugation on gene silencing by RNA interference |
| Q30376502 | Endothelial Thermotolerance Impairs Nanoparticle Transport in Tumors. |
| Q35012825 | Engineering liver therapies for the future |
| Q97636121 | Engineering synthetic breath biomarkers for respiratory disease |
| Q36595374 | Engineering tissues for in vitro applications |
| Q39780105 | Fabrication of 3D hepatic tissues by additive photopatterning of cellular hydrogels |
| Q43635763 | Fabrication of PLGA scaffolds using soft lithography and microsyringe deposition |
| Q36695030 | Fabrication of three-dimensional tissues. |
| Q37267914 | Flow-based pipeline for systematic modulation and analysis of 3D tumor microenvironments |
| Q46143744 | Formation of steady-state oxygen gradients in vitro: application to liver zonation |
| Q33686651 | Functional delivery of siRNA in mice using dendriworms |
| Q36335163 | Genetic Circuits in Salmonella typhimurium |
| Q92549691 | Genetic Encoding of Targeted Magnetic Resonance Imaging Contrast Agents for Tumor Imaging |
| Q89327056 | Genome-scale analysis identifies paralog lethality as a vulnerability of chromosome 1p loss in cancer |
| Q30503483 | Geometric and material determinants of patterning efficiency by dielectrophoresis |
| Q36835748 | Geometric control of vascular networks to enhance engineered tissue integration and function |
| Q33668359 | High-throughput analysis of signals regulating stem cell fate and function |
| Q30502781 | Humanized mice with ectopic artificial liver tissues. |
| Q45178181 | Hypoxic inhibition of 3-methylcholanthrene-induced CYP1A1 expression is independent of HIF-1alpha |
| Q34386810 | Identification and characterization of receptor-specific peptides for siRNA delivery |
| Q36335158 | In Vivo Gene Expression Dynamics of Tumor-Targeted Bacteria. |
| Q46004354 | In vitro liver tissue model established from transgenic mice: role of HIF-1alpha on hypoxic gene expression. |
| Q34375235 | In vitro zonation and toxicity in a hepatocyte bioreactor |
| Q33350022 | In vivo tumor cell targeting with "click" nanoparticles |
| Q27339669 | In-silico patterning of vascular mesenchymal cells in three dimensions |
| Q46713369 | Laminin and fibronectin modulate inner ear spiral ganglion neurite outgrowth in an in vitro alternate choice assay. |
| Q36141137 | Ligand-clustered "patchy" nanoparticles for modulated cellular uptake and in vivo tumor targeting |
| Q36421378 | Local heating of discrete droplets using magnetic porous silicon-based photonic crystals |
| Q35047373 | Magnetic Iron Oxide Nanoworms for Tumor Targeting and Imaging |
| Q42011638 | Magnetically Actuated Protease Sensors for in Vivo Tumor Profiling |
| Q46908741 | Manipulation of liquid droplets using amphiphilic, magnetic one-dimensional photonic crystal chaperones |
| Q97903369 | Mapping functional humoral correlates of protection against malaria challenge following RTS,S/AS01 vaccination |
| Q42682524 | Mass-encoded synthetic biomarkers for multiplexed urinary monitoring of disease |
| Q36179245 | Mathematical framework for activity-based cancer biomarkers |
| Q37064305 | Measuring growth and gene expression dynamics of tumor-targeted S. typhimurium bacteria |
| Q42145728 | Mechanisms of cooperation in cancer nanomedicine: towards systems nanotechnology |
| Q37723654 | Micellar hybrid nanoparticles for simultaneous magnetofluorescent imaging and drug delivery |
| Q63430974 | Microfabricated PLGA scaffolds: a comparative study for application to tissue engineering |
| Q31121030 | Microfabricated platform for studying stem cell fates |
| Q51510970 | Microfluidic organs-on-chips. |
| Q30579408 | Microfluidics-integrated time-lapse imaging for analysis of cellular dynamics |
| Q30479257 | Micromechanical control of cell-cell interactions. |
| Q35133378 | Microscale control of cell contact and spacing via three-component surface patterning |
| Q36824448 | Mitochondrial localization and the persistent migration of epithelial cancer cells |
| Q37234260 | Modulation of hepatocyte phenotype in vitro via chemomechanical tuning of polyelectrolyte multilayers |
| Q40208088 | Multiphase electropatterning of cells and biomaterials |
| Q34014722 | Multiplexed, high-throughput analysis of 3D microtissue suspensions |
| Q24538147 | Nanocrystal targeting in vivo |
| Q37258776 | Nanoparticle amplification via photothermal unveiling of cryptic collagen binding sites |
| Q96130405 | Nanoparticle delivery of immunostimulatory oligonucleotides enhances response to checkpoint inhibitor therapeutics |
| Q42017561 | Nanoparticle self-assembly gated by logical proteolytic triggers |
| Q34490603 | Nanoparticle-mediated delivery of siRNA targeting Parp1 extends survival of mice bearing tumors derived from Brca1-deficient ovarian cancer cells |
| Q34193793 | Nanoparticles that communicate in vivo to amplify tumour targeting |
| Q34369626 | Nanoparticles that sense thrombin activity as synthetic urinary biomarkers of thrombosis. |
| Q37345819 | Nanotechnology: emerging tools for biology and medicine |
| Q48618115 | Neuron-Targeted Nanoparticle for siRNA Delivery to Traumatic Brain Injuries |
| Q91031145 | Non-viral delivery of CRISPR/Cas9 complex using CRISPR-GPS nanocomplexes |
| Q35540080 | Patterning vascular networks in vivo for tissue engineering applications |
| Q98392420 | Peptide Spiders: Peptide-Polymer Conjugates to Traffic Nucleic Acids |
| Q48539572 | Personalized RNA-medicine for pancreatic cancer |
| Q96127257 | Pharmacokinetic tuning of protein-antigen fusions enhances the immunogenicity of T-cell vaccines |
| Q34379373 | Photo- and electropatterning of hydrogel-encapsulated living cell arrays |
| Q38819699 | Photoactivated Spatiotemporally-Responsive Nanosensors of in Vivo Protease Activity. |
| Q37210768 | Plasmonic photothermal heating of intraperitoneal tumors through the use of an implanted near-infrared source |
| Q37640983 | Point-of-care diagnostics for noncommunicable diseases using synthetic urinary biomarkers and paper microfluidics |
| Q44381625 | Polymer replicas of photonic porous silicon for sensing and drug delivery applications |
| Q38683033 | Porous Silicon Nanoparticle Delivery of Tandem Peptide Anti-Infectives for the Treatment of Pseudomonas aeruginosa Lung Infections |
| Q88584498 | Porous silicon-graphene oxide core-shell nanoparticles for targeted delivery of siRNA to the injured brain |
| Q125906431 | Priming agents transiently reduce the clearance of cell-free DNA to improve liquid biopsies |
| Q46112957 | Probing the Cytotoxicity Of Semiconductor Quantum Dots |
| Q43989124 | Probing the role of multicellular organization in three-dimensional microenvironments |
| Q35879638 | Programmable probiotics for detection of cancer in urine. |
| Q60310549 | Protease activity sensors noninvasively classify bacterial infections and antibiotic responses |
| Q37381733 | Protease-triggered unveiling of bioactive nanoparticles |
| Q40286980 | Proteolytic actuation of nanoparticle self-assembly |
| Q24811402 | Quantum dots to monitor RNAi delivery and improve gene silencing |
| Q30537022 | Rapid casting of patterned vascular networks for perfusable engineered three-dimensional tissues |
| Q93064409 | Renal clearable catalytic gold nanoclusters for in vivo disease monitoring |
| Q33670640 | SERS-Coded Gold Nanorods as a Multifunctional Platform for Densely Multiplexed Near-Infrared Imaging and Photothermal Heating. |
| Q40665162 | Self-Sealing Porous Silicon-Calcium Silicate Core-Shell Nanoparticles for Targeted siRNA Delivery to the Injured Brain. |
| Q34239129 | Self-titrating anticoagulant nanocomplexes that restore homeostatic regulation of the coagulation cascade. |
| Q36932862 | Silicon microchips for manipulating cell-cell interaction |
| Q33852033 | Silicon nanoparticles as hyperpolarized magnetic resonance imaging agents |
| Q33933241 | Single cell trapping and DNA damage analysis using microwell arrays |
| Q26776370 | Smart nanosystems: Bio-inspired technologies that interact with the host environment |
| Q27336135 | Statistical dynamics of flowing red blood cells by morphological image processing |
| Q54606553 | Sustained-release synthetic biomarkers for monitoring thrombosis and inflammation using point-of-care compatible readouts. |
| Q37307560 | Synchronized cycles of bacterial lysis for in vivo delivery |
| Q35134003 | Systematic investigation of genetic vulnerabilities across cancer cell lines reveals lineage-specific dependencies in ovarian cancer |
| Q34684423 | Systematic surface engineering of magnetic nanoworms for in vivo tumor targeting |
| Q36951000 | T-cadherin modulates hepatocyte functions in vitro |
| Q46077915 | Targeted quantum dot conjugates for siRNA delivery |
| Q36786792 | Targeted tumor-penetrating siRNA nanocomplexes for credentialing the ovarian cancer oncogene ID4 |
| Q33751710 | Targeting of drugs and nanoparticles to tumors |
| Q37442202 | The compatibility of hepatocytes with chemically modified porous silicon with reference to in vitro biosensors |
| Q48228512 | The pipeline still leaks and more than you think: a status report on gender diversity in biomedical engineering |
| Q30459717 | The smart Petri dish: a nanostructured photonic crystal for real-time monitoring of living cells |
| Q91354939 | Theranostic Layer-by-Layer Nanoparticles for Simultaneous Tumor Detection and Gene Silencing |
| Q35879217 | Three-dimensional tissue fabrication |
| Q41854290 | Tissue-specific gene delivery via nanoparticle coating |
| Q90116138 | Tumor penetrating nanomedicine targeting both an oncomiR and an oncogene in pancreatic cancer |
| Q42374224 | Tumor-Penetrating Delivery of siRNA against TNFα to Human Vestibular Schwannomas |
| Q89127692 | Ultrasensitive tumour-penetrating nanosensors of protease activity |
| Q90834072 | Urinary detection of lung cancer in mice via noninvasive pulmonary protease profiling |
| Q57169954 | iRGD-guided tumor-penetrating nanocomplexes for therapeutic siRNA delivery to pancreatic cancer |
| Q92017355 | Picture a Scientist | cast member | P161 |
| Category:Sangeeta N. Bhatia | wikimedia | |
| Arabic (ar / Q13955) | سانجيتا باهاتيا | wikipedia |
| bn | সঙ্গীতা এন ভাটিয়া | wikipedia |
| Catalan (ca / Q7026) | Sangeeta N. Bhatia | wikipedia |
| Sangeeta Bhatia | wikipedia | |
| Sangeeta Bhatia | wikipedia | |
| Sangeeta N. Bhatia | wikipedia | |
| gl | Sangeeta N. Bhatia | wikipedia |
| hi | संगीता भाटिया | wikipedia |
| mr | संगीता भाटिया | wikipedia |
| pa | ਸੰਗੀਤਾ ਭਾਟੀਆ | wikipedia |
| pnb | سنگیتا بھاٹیا | wikipedia |
| te | సంగీత ఎన్. భాటియా | wikipedia |
Search more.